Business

Inogen Announces Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Outlook

BEVERLY, Mass., February 24, 2026--Inogen Announces Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Outlook

articleInogen, IncFebruary 24, 202617/company/inogen-inc/news/inogen-announces-fourth-quarter-and-full-year-2025-financial-results-and-provides-2026-financial-outlook
Inogen Announces Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Outlook

About this update from Inogen, Inc

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1296,"height":446,"url":"https://media.zenfs.com/en/business-wire.com/dae5da6f432c5850c893c8a988636e8f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/9hEqPvB_X.jQhRcLTc99Nw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMzMDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/dae5da6f432c5850c893c8a988636e8f","width":960,"height":330},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/Br_rWi3K3SITeg_40dvv_g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04MjY7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/dae5da6f432c5850c893c8a988636e8f","width":1200,"height":413}},"lazy":false},{"type":"text","content":"Delivered full year revenue growth of approximately 4%","length":54,"tagName":"p","attribs":{}},{"type":"text","content":"Significantly improved profitability with 2025 net loss of $22.7 million and positive adjusted EBITDA of $2.7 million","length":117,"tagName":"p","attribs":{}},{"type":"text","content":"Well-positioned to accelerate expected 2026 revenue growth and profitability","length":76,"tagName":"p","attribs":{}},{"type":"text","content":"BEVERLY, Mass., February 24, 2026--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the fourth quarter and the full year ended December 31, 2025 and provided 2026 guidance for the first quarter and full year.","length":346,"tagName":"p"},{"type":"text","content":""In 2025, we made significant progress toward our long-term profitability goals while strengthening our product portfolio and improving the fundamentals of our business. Our disciplined operational efficiency contributed to a substantial year-over-year improvement in adjusted EBITDA, culminating in a positive result for the first time since 2021," said Kevin Smith, President and Chief Executive Officer. "Our strong balance sheet with no debt, puts us in a strong position to accelerate innovation, enhance customer engagement, and drive portfolio expansion in 2026 and beyond. We believe these strategic achievements create a solid foundation for future growth and value creation for our shareholders."","length":726,"tagName":"p"},{"type":"text","...

More updates from Inogen, Inc

Inogen, Inc.Inogencash equivalentsinternational salesfinancial resultsimprovementnet loss